Study: NCT01192776

Adverse event: Death during intervention
Serious: yes
Organ System: Nervous system disorders
Frequency: 5 affected / 95 at risk

Adverse event: Cardiac Arrythmia
Serious: yes
Organ System: Cardiac disorders
Frequency: 1 affected / 95 at risk

Adverse event: Major Bleeding
Serious: yes
Organ System: Nervous system disorders
Frequency: 3 affected / 95 at risk

Adverse event: Other
Serious: yes
Organ System: General disorders
Notes: Other Serious Adverse Events
Frequency: 5 affected / 95 at risk

Adverse event: Metabolic acidosis developing >3 hours after initiation of intervention and persisting >3 hours
Serious: no
Organ System: General disorders
Frequency: 2 affected / 95 at risk

Adverse event: Alteration of Skin Integrity
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 3 affected / 95 at risk

Adverse event: Death during intervention
Serious: yes
Organ System: Nervous system disorders
Frequency: 5 affected / 90 at risk

Adverse event: Cardiac Arrythmia
Serious: yes
Organ System: Cardiac disorders
Frequency: 1 affected / 90 at risk

Adverse event: Major Bleeding
Serious: yes
Organ System: Nervous system disorders
Frequency: 2 affected / 90 at risk

Adverse event: Other
Serious: yes
Organ System: General disorders
Notes: Other Serious Adverse Events
Frequency: 10 affected / 90 at risk

Adverse event: Alteration of Skin Integrity
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 3 affected / 90 at risk

Adverse event: Death during intervention
Serious: yes
Organ System: Nervous system disorders
Frequency: 7 affected / 96 at risk

Adverse event: Cardiac Arrythmia
Serious: yes
Organ System: Cardiac disorders
Frequency: 1 affected / 96 at risk

Adverse event: Major Bleeding
Serious: yes
Organ System: Nervous system disorders
Frequency: 1 affected / 96 at risk

Adverse event: Other
Serious: yes
Organ System: General disorders
Notes: Other Serious Adverse Events
Frequency: 6 affected / 96 at risk

Adverse event: Metabolic acidosis developing >3 hours after initiation of intervention and persisting >3 hours
Serious: no
Organ System: General disorders
Frequency: 1 affected / 96 at risk

Adverse event: Alteration of Skin Integrity
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 5 affected / 96 at risk

Adverse event: Death during intervention
Serious: yes
Organ System: Nervous system disorders
Frequency: 12 affected / 83 at risk

Adverse event: Cardiac Arrythmia
Serious: yes
Organ System: Cardiac disorders
Frequency: 7 affected / 83 at risk

Adverse event: Thrombosis
Serious: yes
Organ System: Nervous system disorders
Frequency: 1 affected / 83 at risk

Adverse event: Major Bleeding
Serious: yes
Organ System: Nervous system disorders
Frequency: 1 affected / 83 at risk

Adverse event: Other
Serious: yes
Organ System: General disorders
Notes: Other Serious Adverse Events
Frequency: 11 affected / 83 at risk

Adverse event: Metabolic acidosis developing >3 hours after initiation of intervention and persisting >3 hours
Serious: no
Organ System: General disorders
Frequency: 4 affected / 83 at risk

Adverse event: Alteration of Skin Integrity
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 5 affected / 83 at risk